Paired comparisons efficacy intravenous oral procainamide patients inducible ventricular tachyarrhythmias Thirty-eight patients inducible ventricular tachycardia baseline electrical stimulation underwent electrophysiologic testing intravenous oral administration procainamide sustained ventricular tachycardia hospital cardiac arrest acute myocardial infarction patients Group arrhythmia noninducible intravenous infusion procainamide Oral procainamide dose titration plasma concentration end intravenous study patients Group mean SD procainamide level micrograms/ml intravenous dosing micrograms/ml oral dosing patients ventricular arrhythmia inducible oral therapy comparable plasma procainamide levels intravenous micrograms/ml oral micrograms/ml patients concordant responses comparable intravenous mean micrograms/ml oral micrograms/ml plasma procainamide levels additional patients Group II ventricular tachyarrhythmia inducible intravenous procainamide therapy patients oral therapy similar plasma concentration patients ventricular tachyarrhythmia noninducible treatment oral procainamide mean level micrograms/ml failure intravenous procainamide mean level micrograms/ml 